Literature DB >> 4066925

Humoral immunity against Francisella tularensis after natural infection.

P Koskela, A Salminen.   

Abstract

Forty-two subjects with acute tularemia were studied for the occurrence of C-reactive protein (CRP), and 73 subjects with acute tularemia or experience of the disease within the last 11 years were studied for immunoglobulin M (IgM), IgA, and IgG class-specific antibodies, agglutinating antibodies, and complement-fixing antibodies to Francisella tularensis by using an enzyme-linked immunosorbent assay (ELISA), the tube agglutination test, and a complement-fixing ELISA. The incubation time between infection and the outbreak of symptoms varied from 1 to 10 days, averaging 6.5 days. Elevated CRP concentrations were found in all samples taken in the first 6 days of illness, when the antibodies generally were absent. The highest CRP values, up to 165 mg/liter, occurred in the earliest samples and then decreased rapidly, being undetectable (less than 1 mg/liter) from 1 month after the onset of symptoms. Simultaneous though individually varying formation of IgM, IgA, and IgG class-specific antibodies to F. tularensis was demonstrable by ELISA in all the tularemia patients during the acute stage. In most cases, these antibodies appeared 6 to 10 days after the onset of symptoms, i.e., about 2 weeks after infection, reached their highest values at 4 to 7 weeks, and, despite a decreasing trend in their level, were still present 0.5 to 11 years after onset of tularemia, as demonstrable by the agglutination test and by the complement-fixing ELISA. Of the three methods used, ELISA for IgM, IgA, and IgG proved to be the most efficient for the early serodiagnosis of tularemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066925      PMCID: PMC271862          DOI: 10.1128/jcm.22.6.973-979.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Binding properties and specificity of C-reactive protein.

Authors:  E C Gotschlich; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-03       Impact factor: 11.205

2.  Public Health Weekly Reports for JUNE 25, 1926.

Authors: 
Journal:  Public Health Rep       Date:  1926-06-25       Impact factor: 2.792

3.  Immunoglobulin patterns of antibodies against Brucella in man and animals.

Authors:  P C Wilkinson
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

4.  The tularemia skin test. 325 skin tests in 210 persons: serologic correlation and review of the literature.

Authors:  T M Buchanan; G F Brooks; P S Brachman
Journal:  Ann Intern Med       Date:  1971-03       Impact factor: 25.391

5.  Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia.

Authors:  H E Carlsson; A A Lindberg; G Lindberg; B Hederstedt; K A Karlsson; B O Agell
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

6.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

7.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.

Authors:  R F Mortensen; A P Osmand; T F Lint; H Gewurz
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

9.  Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP.

Authors: 
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  The liver as the site of C-reactive protein formation.

Authors:  J Hurlimann; G J Thorbecke; G M Hochwald
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

View more
  41 in total

1.  Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.

Authors:  Ravinder Kaur; Shan Chen; Maria T Arévalo; Qingfu Xu; Yanping Chen; Mingtao Zeng
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

2.  Francisella tularensis Exposure Among National Park Service Employees During an Epizootic: Devils Tower National Monument, Wyoming, 2015.

Authors:  Alexia Harrist; Cara Cherry; Natalie Kwit; Katie Bryan; Ryan Pappert; Jeannine Petersen; Danielle Buttke; David Wong; Christina Nelson
Journal:  Vector Borne Zoonotic Dis       Date:  2018-12-01       Impact factor: 2.133

3.  Tularemia presenting as pulmonary nodules in an immunocompromised patient.

Authors:  Tony Alias; Mohammad Kazem Fallahzadeh; Mezgebe Berhe
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

4.  Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.

Authors:  Henrik Eliasson; Per Olcén; Anders Sjöstedt; Margareta Jurstrand; Erik Bäck; Sören Andersson
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

5.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis.

Authors:  Martien Broekhuijsen; Pär Larsson; Anders Johansson; Mona Byström; Ulla Eriksson; Eva Larsson; Richard G Prior; Anders Sjöstedt; Richard W Titball; Mats Forsman
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 7.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

8.  Detection of Francisella tularensis within infected mouse tissues by using a hand-held PCR thermocycler.

Authors:  Peter A Emanuel; Ryan Bell; Jessica L Dang; Rebecca McClanahan; John C David; Robert J Burgess; Joseph Thompson; Lisa Collins; Ted Hadfield
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Investigating an airborne tularemia outbreak, Germany.

Authors:  Anja M Hauri; Iris Hofstetter; Erik Seibold; Philip Kaysser; Juergen Eckert; Heinrich Neubauer; Wolf D Splettstoesser
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

10.  Evaluation of In-House and Commercial Serological Tests for Diagnosis of Human Tularemia.

Authors:  Hadjila Yanes; Aurélie Hennebique; Isabelle Pelloux; Sandrine Boisset; Dominique J Bicout; Yvan Caspar; Max Maurin
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.